Aetna Medical Policy Updates – December 2022

Click here to view the Aetna Medical Policy Updates »

December 2022 Aetna Medical Policy Updates:

• Abatacept (Orencia)
• Abatacept (Orencia) [Medicare]
• Acupuncture
• Adalimumab (Humira)
• ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP)
• Allergy and Hypersensitivity
• Anakinra (Kineret)
• Androgens and Anabolic Steroids
• Atezolizumab (Tecentriq)
• Automated Audiometry
• Bezlotoxumab (Zinplava)
• Biofeedback
• BRCA Testing, Prophylactic Mastectomy, and Prophylactic Oophorectomy
• Breast Reconstructive Surgery
• Bronchial Thermoplasty
• Buprenorphine Implant (Probuphine) and Extended-Release Injectable (Sublocade)
• Cabazitaxel (Jevtana)
• Calcitonin Injection
• Canakinumab (Ilaris)
• Cardiac Contractility Modulation (CCM) Therapy
• Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage
• Cataract Surgery
• Certolizumab Pegol (Cimzia)
• Cetuximab (Erbitux)
• Chemical Aversive Conditioning for Alcoholism
• Chiari Malformation Decompression Surgery
• Clofarabine (Clolar)
• Clotting Factors
• Complex Regional Pain Syndrome (CRPS)/Reflex Sympathetic Dystrophy (RSD): Diagnosis
• Cosmetic Surgery
• Critical Flicker Fusion
• Cryoablation
• Dermabrasion, Chemical Peels, and Acne Surgery
• Dinutuximab (Unituxin)
• Docetaxel (Taxotere)
• Double Balloon Enteroscopy
• Drug Testing in Pain Management and Substance Use Disorder Treatment
• Elbow Arthroplasty
• Electroretinography
• Embolization: Selected Procedures
• Endolymphatic Hydrops (Meniere’s Disease) Tests
• Enfortumab vedotin-ejfv (Padcev)
• Epidural Patching
• Etanercept
• External Breast Prosthesis
• Gemcitabine (Gemzar)
• Gender Affirming Surgery
• Givosiran (Givlaari)
• Golimumab (Simponi and Simponi Aria)
• Golimumab (Simponi and Simponi Aria) [Medicare]
• Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Genetic Diseases
• Hematopoietic Cell Transplantation for Myelofibrosis
• Hematopoietic Cell Transplantation for Non-Hodgkin’s Lymphoma
• Hematopoietic Colony-Stimulating Factors (CSFs)
• Hematopoietic Colony-Stimulating Factors (CSFs) [Medicare]
• Hepatitis Screening
• Ibalizumab-uiyk (Trogarzo)
• Infliximab
• Infliximab [Medicare]
• Influenza Rapid Diagnostic Tests
• Intensive Cardiac Rehabilitation Programs
• Irinotecan Liposome Injection (Onivyde)
• Ketamine for the Treatment of Depression and Other Psychiatric Disorders
• Leadless Cardiac Pacemaker
• Liver and Other Neoplasms – Treatment Approaches
• Lysosomal Storage Disorder Treatments
• Manipulation Under General Anesthesia
• Mifepristone
• Mifepristone
• Mometasone Furoate Sinus Implant (Sinuva)
• Myopathy: Selected Tests
• Naltrexone Implants
• Nerve Blocks
• Optical Coherence Tomography of the Middle Ear
• Organ Prolapse: Selected Procedures
• Osteoarthritis of the Knee: Selected Treatments
• Oxaliplatin (Eloxatin)
• Panitumumab (Vectibix)
• Parenteral Immunoglobulins
• Parenteral Immunoglobulins [Medicare]
• Pemetrexed (Alimta)
• Percutaneous Mitral Valve and Tricuspid Valve Repair
• Polymerase Chain Reaction Testing: Selected Indications
• Prostate Cancer Vaccine
• Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators
• Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators [Medicare]
• Quantitative Pupillometry/Pupillography
• Radiopharmaceuticals Strontium-89 (Metastron) and Samarium-153 (Quadramet) for Malignant Bone Pain
• Radiostereometric Analysis for Migration and Wear of Orthopedic Implants
• Rheumatic Diseases: Selected Tests
• Rilonacept (Arcalyst)
• Sacituzumab govitecan-hziy (Trodelvy)
• Secukinumab (Cosentyx)
• Skilled Home Private Duty Nursing Care
• Tocilizumab (Actemra)
• Tocilizumab (Actemra) [Medicare]
• Trabectedin (Yondelis)
• Transperineal Placement of Biodegradable Material (SpaceOAR™) for Prostate Cancer
• Transrectal Ultrasound
• Transvaginal Ultrasonography
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) [Medicare]
• Ultrasound Guidance – Selected Indications
• Urinary Incontinence
• Ustekinumab (Stelara)
• Ustekinumab (Stelara) [Medicare]
• Vaccines for Travel
• Vincristine Sulfate Liposome Injection (Marqibo)

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.